Every year, over 100,000 people die from snakebites worldwide, with existing antivenom being ineffective due to its high cost, limited efficacy, and potential for allergic reactions. A recent study published in the journal Nature proposes a potential solution: a novel antivenom created by synthesizing 'nanobodies' from camels and llamas. This innovative antivenom has shown broad-spectrum protection against 17 out of 18 species of African venomous snakes, excluding the eastern green mamba, and has outperformed existing products in most cases. The researchers estimate that it will take approximately 3 years for the technology to be ready for human clinical trials. This breakthrough has the potential to revolutionize snakebite treatment, making it safer, more cost-effective, and more effective. The study's findings have significant implications for public health, particularly in regions where snakebites are a major concern. The development of this innovative antivenom could save countless lives and improve the quality of life for those affected by snakebites.